Annovis Bio stock hits 52-week low at $2.59 amid sharp decline
Annovis Bio Inc. (ANVS) stock has tumbled to a 52-week low, reaching a price level of just $2.59. With a market capitalization of $49.7 million, InvestingPro analysis indicates the stock is currently ...
CRBP stock touches 52-week low at $9.1 amid market challenges
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, trading at $9.1, reflecting a period of significant pressure for the biopharmaceutical company. With a market ...